Jahrgang 2 (2018), Ausgabe 3
Complete issue
Editorial
Editorial
Seite 119 - 120
Articles
Reports
Biosimilars ∙ Regulatory Frameworks for Marketing Authorisation of Biosimilars: Where Do We Go From Here?
Seite 149 - 154
Germany ∙ Liability for Medicinal Products and the Right to Disclosure under German Law
Seite 155 - 166
United Kingdom ∙ Recent Developments in UK Medicines Regulation
Seite 167 - 168
Case Notes
Jurisdiction
Jurisdiction
Seite 174 - 175
Legislation
EU Pharmaceutical Law and Policy
Seite 176